- Home
- IBIO vs GDO Comparison
IBIO vs GDO Comparison
Compare IBIO & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.88
Company Overview
Basic Information| Metric | IBIO | GDO |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.2M | 80.4M |
| IPO Year | 2009 | 2009 |
Fundamental Metrics
Financial Performance| Metric | IBIO | GDO |
|---|---|---|
| Price | $1.88 | $10.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.75 | N/A |
| AVG Volume (30 Days) | ★ 672.8K | 23.5K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $10.52 |
| 52 Week High | $3.82 | $12.15 |
Technical Indicators
Market Signals| Indicator | IBIO | GDO |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 35.42 |
| Support Level | $1.70 | $10.57 |
| Resistance Level | $2.00 | $11.15 |
| Average True Range (ATR) | 0.17 | 0.11 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 64.25 | 3.03 |
Price Performance
Historical Comparison IBIO
GDO
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.